Advertisement

Experientia

, Volume 27, Issue 7, pp 799–801 | Cite as

Functional reinnervation of cat sympathetic ganglia with splenic nerve homografts

  • S. H. Koslow
  • M. Stepita-Klauco
  • L. Olson
  • E. Giacobini
Specialia Physiologica

Keywords

Dopa Sympathetic Ganglion Compound Action Potential Repetitive Stimulation Sympathetic Chain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Zusammenfassung

Sympathische Ganglien, wenn mit Fasern desN. splenicus reinnerviert, bilden 2 pharmakologisch differente Synapsengruppen: normale, vom cholinergischen Typ und ca. 20% exitatorische vom «monoaminergischen» Typ, wenn sie von adrenergen Fasern reinnerviert wurden.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    L. Volle, A. Rev. Pharmac.9, 135 (1969).CrossRefGoogle Scholar
  2. 2.
    R. M. Eccles andB. Libet, J. Physiol., Lond.157, 484 (1961).CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    A. S. Marrazzi, J. Pharmac. exp. Ther.65, 395 (1939).Google Scholar
  4. 3a.
    K. Lissak, Am. J. Physiol.127, 263 (1939).Google Scholar
  5. 3b.
    R. M. Eccles andB. Libei, J. Physiol., Lond.157, 484 (1961).CrossRefPubMedPubMedCentralGoogle Scholar
  6. 3c.
    E. Costa, A. M. Revzin, R. Kuntzman, S. Spector andB. B. Brodie, Science133, 1822 (1961).CrossRefPubMedGoogle Scholar
  7. 3d.
    B. Libet, J. Physiol., Lond.174, 1 (1964).CrossRefPubMedPubMedCentralGoogle Scholar
  8. 3e.
    B. Libet, J. Neurophysiol.30, 494 (1967).PubMedGoogle Scholar
  9. 3f.
    Y. Dunant andM. Dolivo, J. Physiol., Paris59, 281 (1967).Google Scholar
  10. 3g.
    B. Libet andT. Tosaka, J. Neurophysiol.32, 43 (1969).PubMedGoogle Scholar
  11. 3h.
    B. Libet andH. Kobayashi, Science164, 1530 (1969).CrossRefPubMedGoogle Scholar
  12. 3i.
    T. Tosaka andB. Libet, Fedn Proc.29, 716 (1970).Google Scholar
  13. 3j.
    B. Libet, Fedn Proc., in press (1971).Google Scholar
  14. 4.
    E. Costa, A. M. Revzin, R. Kuntzman, S. Spector andB. B. Brodie, Science133, 1822 (1961).CrossRefPubMedGoogle Scholar
  15. 5.
    T. H. W. Williams, Nature214, 309 (1967).CrossRefPubMedGoogle Scholar
  16. 6.
    K. Norberg andF. Sjoqvist, Pharmac. Rev.18, 743 (1966).Google Scholar
  17. 8.
    J. E. Pascoe, J. Physiol., Lond.132, 242 (1956).CrossRefPubMedPubMedCentralGoogle Scholar
  18. 9.
    S. Obrador andJ. B. Odoriz, J. Physiol., Lond.86, 269 (1936).CrossRefPubMedPubMedCentralGoogle Scholar
  19. 10.
    L. G. Elfvin, J. Ultrastruct. Res.1, 428 (1958).CrossRefPubMedGoogle Scholar
  20. 11.
    B. Rexed andU. S. von Euler, Acta psychiat. neurol. scand.26, 61 (1951).CrossRefGoogle Scholar
  21. 12.
    U. S. von Euler, J. Physiol., Lond.107, 10 P (1948).Google Scholar
  22. 13.
    H. Corrodi andG. Jonsson, J. Histochem. Cytochem.15, 65 (1967).CrossRefGoogle Scholar
  23. 14.
    K. A. Norberg, Brain Res.5, 125 (1967).CrossRefPubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1971

Authors and Affiliations

  • S. H. Koslow
    • 1
    • 2
  • M. Stepita-Klauco
    • 1
  • L. Olson
    • 1
  • E. Giacobini
    • 1
  1. 1.Department of Pharmacology and HistologyKarolinska InstituteStockholmSweden
  2. 2.National Institute of Mental Health, Laboratory of Preclinical PharmacologySaint Elizabeths HospitalWashingtonUSA

Personalised recommendations